Emulate
 | This article relies largely or entirely on a single source. (November 2014) |
Emulate is a startup company focused on the commercialization of the Organ on a chip - a tissue-based technology that replicates human organ-level function that is used to model organs in healthy and diseased states. The platform has applications in pharmaceutical research and development, testing how different chemicals and foods affect human health, and personalized therapy.[1] The company was spun out from the Wyss Institute for Biologically Inspired Engineering at Harvard University, where the technology was initially invented and then extensively developed. Donald Ingber founded the company around 2013.[1] James Coon is a co-founder and been the CEO since the company was incorporated. Geraldine Hamilton is the company's President and Chief Science Officer since late 2014.[1]
References
- ^ a b c Piesing, Mark (August 23, 2014). "How tech could spell the end of animals in drugs testing". The Guardian. London.
{{cite news}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help)
 | This article related to a manufacturing company is a stub. You can help Wikipedia by expanding it. |